EAGLE PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2022.
  • Eagle Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $4.13M, a 15.4% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $17.2M, a 1.96% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $25.8M, a 532% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $4.08M, a 61.8% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $10.7M, a 39.1% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $25.8M +$21.7M +532% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $4.08M -$6.61M -61.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $10.7M +$3M +39.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $7.69M +$5.55M +260% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $2.14M -$18.9M -89.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $21M +$49M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$28M -$28M -934300% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $3K* +$1.3M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 -$1.3M -$396K -44% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 -$899K -$118K -15.1% Oct 1, 2012 Sep 30, 2013 10-K 2016-02-29
2012 -$781K Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.